CXXC5

Across TCGA pan-cancer cohorts, CXXC5 Mutation is linked to patient survival in 4 of 34 cancer types, making it a survival-associated CXXC5 data layer compared with 25 for mass-spec protein and 3 for mass-spec protein.

The strongest signal is observed in stomach adenocarcinoma (STAD), where higher CXXC5 Mutation is associated with worse overall survival. In most high-consensus cancer types, elevated CXXC5 expression acts as an unfavorable survival marker, although some lineages such as UCEC show a favorable association.

STAD, SKCM, and SCLC are the cancer types where CXXC5 Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
STAD	OS	Median	IV	0.001	0.544	<.001	12	view →
SKCM	OS	Median	III,IV	0.289	0.729	.004	5	view →
SCLC	DFS	Median	All	0.292	0.633	.034	3	view →
UCEC	DFS	Median	All	1.000	0.619	.034	2	view →

Pink = unfavorable, green = favorable. Showing the 4 strongest of 4 lineages.

CXXC5–STAD (OS)

Open the STAD breakdown →